364th MEETING OF THE MEDICAL SCHOOL COUNCIL
3 p.m., Wednesday, October 17, 2007
School of Medicine Administration, Board Room 103
PRESENT: Drs. Argani, Armstrong, Bluemke, Diana Scorpio (for Brayton), Cooke, Cromwell, Dagnelie, Efron, Goldstein, Gould, Honeycutt, Jia, Maragakis, McCarthy, Mooney, Pidcock, Schramm, Siberry, Stivers, Yaster, Zellars, Mr. Nguyen Mss. Fairman, Foy, and Oliver.
ABSENT: Drs. Allaf, Bergles, Bhatti, Chan, Choi, Cormack, Flynn, Geller, Gultekin, Halushka, Huang, Kravet, Leahy, MacDonald, Magaziner, Mears, Peters, Robinson, Sterni, Tompkins, Tufaro, Whitmore, Woolf, Yehia, Ms. Cohen.
GUESTS: Drs. Baumgartner, Sugarman, and Vogel, Mr. Wilczek
The minutes of the September 19, 2007 meeting were approved.II. Professional Development Office (PDO) – Dr. Donna Vogel, Director
Dr. Vogel, the newly appointed director of the JHMI Professional Development Office presented an overview of the services the PDO offers to graduate students, postdoctoral fellows and junior faculty. Dr. Vogel comes to Hopkins after a 25 year career at the NIH. Her most recent NIH administrative appointment was in the Fellowship Office of the NCI. Dr. Vogel is a medical endocrinologist with an interest in reproductive medicine; her Ph.D. degree is in developmental biology.
The PDO was established seven years ago and serves the East Baltimore campus. Dr. Vogel reviewed the courses currently offered which include small interactive courses for faculty and senior fellows (GrantCraft), workshops and events targeted to the first job search, employer information sessions, introductory courses for students and fellows on funding, writing, presenting, and teaching skills, and panels and speakers covering a wide range of scientific career paths.
Dr. Vogel plans to offer new courses in partnership with other Hopkins entities. There are planned courses in laboratory management and research leadership which the NIH encourages for NRSA trainees. Additional courses planned include revising and resubmitting grant applications, with separate sessions for R & K grants and targeted courses in making the most out of training at Johns Hopkins and mentoring relationships. Mock study sessions are also planned.
Dr. Vogel is available to attend departmental and divisional meetings to inform faculty of the services offered and to ascertain trainee needs for additional courses.
It was suggested an article in Change would be a good mechanism to inform the academic community of the services currently available.
Dr. Honeycutt thanked Dr. Vogel for her presentation and made reference to the web-site, www.hopkinsmedicine.org/pdo for details of current offerings.III. Report on the Clinical Practice Association (CPA) – Dr. Bill Baumgartner, Vice Dean of Clinical Affairs, and Ken Wilczek, Associate Dean of Clinical Practice
Dr. Baumgartner outlined the history and governance structure of the CPA. The association is the faculty group practice encompassing all full time faculty providing clinical care in five major practice sites. The practice accounts for over 68,000 admissions and one million outpatient visits annually. Clinical income ($515 million) supports 44.8% of the school’s budget.
Dr. Baumgartner reviewed the governance structure and outlined the responsibilities of the five major administrative committees in the structure. He commented on the broad faculty representation on the governing committees.
A ten year “mix of business” based on charges was reviewed. It was noted the percentage of Medicare business was unchanged. The Medicaid business increased from 9.4% to 11.9% and managed care increased from 20.7% to 34.8%. There was a substantial decrease in commercial insurance from 9.3% to 1.2%. The international business has also decreased from 2.8% to 1.4%, mostly due to the 9/11 event.
Mr. Wilczek reviewed the principles governing contracting and the centralized professional fee billing process that was restructured in 1998. He presented key 2007 charge and collection statistics from East Baltimore and Bayview. Billing compliance and government affairs efforts were also addressed.
The following areas were addressed in discussion following the presentation:
- How aggressive should we be in our billing operation? Are we being sensitive to patients?
- Billing for patients in clinical trials is frequently mixed-up, causing frustration. There is an ongoing joint effort to address this issue between Dr. Dan Ford’s office and the CPA.
- Non-compete clause: why do we have it and how often is it enforced? Dr. Baumgartner noted most academic medical centers have a non-compete clause to protect the institution from faculty who build up a high volume practice and then leave the university to practice in a local area. Dr. Baumgartner noted there is a provision in the policy for a buy-out and exceptions made for employment in a government position or a position at the University of Maryland. Dr. Baumgartner pointed out that use of the non-compete clause is a departmental decision.
Dr. Honeycutt thanked Dr. Baumgartner and Mr. Wilczek for their presentation.
IV. School of Medicine Embryonic Stem Cell Research Oversight (ESCRO) Committee– Dr. Jeremy Sugarman, Co-Chair
Dr. Sugarman provided an overview of issues in human embryonic stem cell (hESC) research. He addressed ethical issues including the moral status of the embryo and public and private funding. He summarized the various funding mechanisms and prohibitions in place in several states. Noting a need for a system of oversight for hESC research, the National Research Council and the Institute of Medicine issued guidelines for hESC research. One recommendation was that each institution establish an Embryonic Stem Cell Research Oversight (ESCRO) committee to review and monitor all proposals to conduct hES cell research. The National Academy guidelines clearly articulated the responsibilities of the ESCRO. An ESCRO Committee was established at Johns Hopkins with Drs. Jeremy Sugarman and Carol Greider as co-chairs. The ESCRO Committee will provide ethical oversight and review hESC research and/or somatic cell nuclear transfer involving human cells, will be a consultative body for related research, and will work in collaboration with other bodies charged with research oversight. The ESCRO is a multidisciplinary committee appointed by the Vice Dean for Research. It will function similar to the Institutional Review Board and the Institutional Animal Care and Use Committee. Dr. Sugarman noted the Maryland Stem Cell Research Act of 2006 has created a fund to promote state funded stem cell research and cures through grants and loans to public and private entities in Maryland.
There are educational models on the ESCRO web-site, www.hopkinsmedicine.org/research/escro, that individuals must take if involved in stem cell research.
Dr. Honeycutt thanked Dr. Sugarman for his presentation.
V. Other Business
Dr. Honeycutt announced:
Dean Miller will address the council in November. Questions for Dr. Miller should be submitted to Drs. Honeycutt or Zellars in advance of the meeting.
The 2007 Faculty Survey is on-going; to date there is a 15% participation rate. Medical School Council members were asked to encourage their constituents to participate.
There is a vacancy in the member-at-large position. Suggested names should be submitted to Drs. Honeycutt or Zellars for election at a future meeting.
There being no further business this meeting was adjourned at 4:50 p.m.
Mary E. Foy
Future Medical School Council meetings:
All meetings will be held in the School of Medicine Board Room (SOM 103), 3:00 to 5:00 p.m.
November 14, 2007
December 12, 2007
January 23, 2008
February 20, 2008
March 19, 2008
April 16, 2008
May 14, 2008
June 18, 2008